CIBC Private Wealth Group LLC Decreases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

CIBC Private Wealth Group LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 482,830 shares of the medical equipment provider’s stock after selling 14,943 shares during the period. CIBC Private Wealth Group LLC owned about 0.14% of Intuitive Surgical worth $262,669,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of ISRG. Atala Financial Inc acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical in the 4th quarter valued at $28,000. Summit Securities Group LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth $30,000. Finally, Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth $31,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $491.84 on Friday. The company has a market cap of $175.18 billion, a P/E ratio of 76.73, a P/E/G ratio of 5.85 and a beta of 1.43. The stock has a 50-day moving average of $556.28 and a two-hundred day moving average of $532.68. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent research reports. Robert W. Baird lowered their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 18th. Raymond James boosted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Barclays lifted their price objective on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Stifel Nicolaus upped their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Finally, JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.